Novo’s Wegovy Approved After Superior Weight-Loss Impact Shown

Novo Nordisk A/S gained U.S. approval for its therapy that helped patients lose about 15% of their body weight on average in trials, an alternative to
Real Advice for Diabetes Weight-Loss

“Instead of aiming for arbitrary goal weights or focusing on appearance, we care about the health benefits associated with weight loss,” says Louis Aronne, M.D.,